<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">HBV </span>
   <span class="font20">(.%) </span>
   <span class="font18">hepatitis </span>
   <span class="font18">(.–.) </span>
   <span class="font16">HIV </span>
   <span class="font16">Health </span>
   <span class="font15">[]. </span>
   <span class="font15">criteria </span>
   <span class="font14">adults </span>
   <span class="font14">AVT </span>
   <span class="font14">data </span>
   <span class="font14">therapy </span>
   <span class="font14">{border-style </span>
   <span class="font13">DNA </span>
   <span class="font13">Sciences </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">;():–. </span>
   <span class="font13">ALT </span>
   <span class="font13">study </span>
   <span class="font13">Medicine </span>
   <span class="font13">Zambia </span>
   <span class="font13">men </span>
   <span class="font13">monoinfected </span>
   <span class="font13">patients </span>
   <span class="font13">EASL </span>
   <span class="font13">HBsAg-positivity </span>
   <span class="font13">chronic </span>
   <span class="font13">individuals </span>
   <span class="font13">treatment </span>
   <span class="font13">virus </span>
   <span class="font12">Pathogens </span>
   <span class="font12">infection </span>
   <span class="font12">review </span>
   <span class="font12">(–) </span>
   <span class="font12">Africa </span>
   <span class="font12">HBsAg-positive </span>
   <span class="font12">Hepatitis </span>
   <span class="font12">age </span>
   <span class="font12">based </span>
   <span class="font12">health </span>
   <span class="font12">proportion </span>
   <span class="font12">sample </span>
   <span class="font12">women </span>
   <span class="font12">(.) </span>
   <span class="font12">CI, </span>
   <span class="font12">Viral </span>
   <span class="font12">defined </span>
   <span class="font12">guidelines </span>
   <span class="font12">increased </span>
   <span class="font12">versus </span>
   <span class="font12">Reference </span>
   <span class="font12">University </span>
   <span class="font12">[], </span>
   <span class="font12">eligibility </span>
   <span class="font12">liver </span>
   <span class="font12">need </span>
   <span class="font12">odds </span>
   <span class="font12">population </span>
   <span class="font11">ART </span>
   <span class="font11">Africa. </span>
   <span class="font11">Biology </span>
   <span class="font11">Median </span>
   <span class="font11">Treat-B </span>
   <span class="font11">U/L </span>
   <span class="font11">Zambian </span>
   <span class="font11">antiviral </span>
   <span class="font11">cirrhosis </span>
   <span class="font11">eligible </span>
   <span class="font11">met </span>
   <span class="font11">ratio </span>
   <span class="font11">sex </span>
   <span class="font11">IU/ml </span>
   <span class="font11">Liver </span>
   <span class="font11">World </span>
   <span class="font11">compared </span>
   <span class="font11">elevation </span>
   <span class="font11">including </span>
   <span class="font11">pregnant </span>
   <span class="font11">px; </span>
   <span class="font11">risk </span>
   <span class="font11">similar </span>
   <span class="font11">survey </span>
   <span class="font11">using </span>
   <span class="font11">{font-family </span>
   <span class="font11">&amp;gt; </span>
   <span class="font11">&amp;lt;. </span>
   <span class="font11">CI) </span>
   <span class="font11">Ministry </span>
   <span class="font11">Study </span>
   <span class="font11">assessed </span>
   <span class="font11">associated </span>
   <span class="font11">font-size </span>
   <span class="font11">general </span>
   <span class="font11">household </span>
   <span class="font11">infection. </span>
   <span class="font11">reported </span>
   <span class="font11">rural </span>
   <span class="font11">testing </span>
   <span class="font11">used </span>
   <span class="font11">&amp;gt;, </span>
   <span class="font11">&amp;gt;. </span>
   <span class="font11">(i.e., </span>
   <span class="font11">.%; </span>
   <span class="font11">Africa, </span>
   <span class="font11">African </span>
   <span class="font11">Clinical </span>
   <span class="font11">European </span>
   <span class="font11">HBsAg </span>
   <span class="font11">Life </span>
   <span class="font11">Lusaka, </span>
   <span class="font11">Men </span>
   <span class="font11">Microbial </span>
   <span class="font11">antiretroviral </span>
   <span class="font11">coinfected </span>
   <span class="font11">decompensated </span>
   <span class="font11">diagnosed </span>
   <span class="font11">did </span>
   <span class="font11">double; </span>
   <span class="font11">evaluated </span>
   <span class="font11">evaluation </span>
   <span class="font11">fibrosis </span>
   <span class="font11">global </span>
   <span class="font11">higher </span>
   <span class="font11">income </span>
   <span class="font11">kPa </span>
   <span class="font11">low </span>
   <span class="font11">physical </span>
   <span class="font11">sciences </span>
   <span class="font11">survey, </span>
   <span class="font11">viral </span>
   <span class="font11">years </span>
   <span class="font11">(.% </span>
   <span class="font11">(AOR, </span>
   <span class="font11">.–.) </span>
   <span class="font11">ALT, </span>
   <span class="font11">Association </span>
   <span class="font11">Gastroenterology </span>
   <span class="font11">HBsAg-positives </span>
   <span class="font11">Infectious </span>
   <span class="font11">Microbiology </span>
   <span class="font11">Organisms </span>
   <span class="font11">Viruses </span>
   <span class="font11">WHO, </span>
   <span class="font11">ZamPHIA </span>
   <span class="font11">analysis, </span>
   <span class="font11">available </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">countries </span>
   <span class="font11">developed </span>
   <span class="font11">elimination </span>
   <span class="font11">guidelines. </span>
   <span class="font11">incidence </span>
   <span class="font11">index </span>
   <span class="font11">large </span>
   <span class="font11">likely </span>
   <span class="font11">link </span>
   <span class="font11">men, </span>
   <span class="font11">original </span>
   <span class="font11">pathogens </span>
   <span class="font11">performed </span>
   <span class="font11">population-based </span>
   <span class="font11">recent </span>
   <span class="font11">score </span>
   <span class="font11">signs </span>
   <span class="font11">solid; </span>
   <span class="font11">status </span>
   <span class="font11">taking </span>
   <span class="font11">tested </span>
   <span class="font11">transmission </span>
   <span class="font11">use </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">&amp;lt;, </span>
   <span class="font10">./j.jhep... </span>
   <span class="font10">./journal.pone..tTable </span>
   <span class="font10">.–.). </span>
   <span class="font10">APRI </span>
   <span class="font10">AST-to-platelet </span>
   <span class="font10">AVT. </span>
   <span class="font10">Abbreviations: </span>
   <span class="font10">Disease </span>
   <span class="font10">Global </span>
   <span class="font10">HBV, </span>
   <span class="font10">HBsAg-positivity. </span>
   <span class="font10">HCC </span>
   <span class="font10">HIV-HBV </span>
   <span class="font10">IU/ml, </span>
   <span class="font10">Immunodeficiency </span>
   <span class="font10">International </span>
   <span class="font10">Lancet </span>
   <span class="font10">Lentivirus: </span>
   <span class="font10">National </span>
   <span class="font10">Research </span>
   <span class="font10">Retroviruses </span>
   <span class="font10">Survey </span>
   <span class="font10">Viruses: </span>
   <span class="font10">Zambia. </span>
   <span class="font10">Zambia[], </span>
   <span class="font10">ages </span>
   <span class="font10">antigen </span>
   <span class="font10">assess </span>
   <span class="font10">bold </span>
   <span class="font10">care </span>
   <span class="font10">cirrhosis, </span>
   <span class="font10">community </span>
   <span class="font10">confidence </span>
   <span class="font10">courier; </span>
   <span class="font10">criteria, </span>
   <span class="font10">current </span>
   <span class="font10">draftWriting </span>
   <span class="font10">em; </span>
   <span class="font10">facility </span>
   <span class="font10">gap </span>
   <span class="font10">hepatology. </span>
   <span class="font10">history </span>
   <span class="font10">hospital </span>
   <span class="font10">identified </span>
   <span class="font10">inclusion </span>
   <span class="font10">life </span>
   <span class="font10">major </span>
   <span class="font10">male </span>
   <span class="font10">medical </span>
   <span class="font10">participants </span>
   <span class="font10">performance </span>
   <span class="font10">pt;} </span>
   <span class="font10">referred </span>
   <span class="font10">slightly </span>
   <span class="font10">study, </span>
   <span class="font10">therapy. </span>
   <span class="font10">times </span>
   <span class="font10">years, </span>
  </p>
 </body>
</html>
